These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 30316990

  • 1. Polymerase-1 pathway activation in acute multiple sclerosis relapse.
    Achiron A, Zilkha-Falb R, Feldman A, Bovim M, Rozen O, Sarova-Pinhas I, Magalashvili D, Dolev M, Menascu S, Gurevich M.
    Autoimmun Rev; 2018 Dec; 17(12):1235-1239. PubMed ID: 30316990
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Experimental Autoimmune Encephalomyelitis Ameliorated by Passive Transfer of Polymerase 1-Silenced MOG35-55 Lymphatic Node Cells: Verification of a Novel Therapeutic Approach in Multiple Sclerosis.
    Zilkha-Falb R, Gurevich M, Achiron A.
    Neuromolecular Med; 2017 Sep; 19(2-3):406-412. PubMed ID: 28755038
    [Abstract] [Full Text] [Related]

  • 4. Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.
    Achiron A, Mashiach R, Zilkha-Falb R, Meijler MM, Gurevich M.
    J Neuroimmunol; 2013 Oct 15; 263(1-2):91-7. PubMed ID: 23998422
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse.
    Achiron A, Feldman A, Mandel M, Gurevich M.
    Ann N Y Acad Sci; 2007 Jun 15; 1107():155-67. PubMed ID: 17804543
    [Abstract] [Full Text] [Related]

  • 8. Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.
    De Andres C, García MI, Goicoechea H, Martínez-Ginés ML, García-Domínguez JM, Martín ML, Romero-Delgado F, Benguría A, Sanjurjo M, López-Fernández LA.
    Pharmacogenomics J; 2018 Jan 15; 18(1):98-105. PubMed ID: 27670768
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. RAM-589.555 a new Polymerase-1 inhibitor as innovative targeted-treatment for multiple sclerosis.
    Achiron A, Zilkha-Falb R, Mashiach R, Gurevich M.
    J Neuroimmunol; 2017 Jan 15; 302():41-48. PubMed ID: 27908532
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis.
    Hewes D, Tatomir A, Kruszewski AM, Rao G, Tegla CA, Ciriello J, Nguyen V, Royal W, Bever C, Rus V, Rus H.
    Exp Mol Pathol; 2017 Apr 15; 102(2):191-197. PubMed ID: 28109694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.